Comparative Effectiveness Research & the Cochrane Eyes & Vision Group

比较效果研究

• 批准号: 8288211
• 负责人: KAY DICKERSIN
• 金额: $ 133.85万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-01 至 2017-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8288211
• 关键词: Academy; Achievement; Address; Age; American; Area; Blindness; Caring; Clinical; Clinical Research; Clinical Trials; Code; Collaborations; Data; Databases; Development; Diabetic Retinopathy; Diagnosis; Diagnostic; Diagnostic tests; Education; Educational workshop; Effectiveness of Interventions; Electronics; Enrollment; Ensure; Eye; Eye diseases; Guidelines; Health; Healthcare; Individual; Intervention; Journals; Libraries; Link; Manuscripts; Meta-Analysis; Methods; Morbidity - disease rate; Ophthalmology; Outcome; Participant; Pattern; Peer Review; Play; Principal Investigator; Printed Media; Process; Publications; Publishing; Quality of life; Reporting; Research; Research Infrastructure; Research Personnel; Research Training; Resources; Retrieval; Role; Societies; Source; Training; Update; Vision; Vision Disorders; Vision research; Visual impairment; Work; abstracting; base; comparative effectiveness; control trial; diabetic cataract; editorial; effectiveness research; evidence base; experience; improved; member; prevent; prospective; symposium; systematic review; vision science; web site

DESCRIPTION (provided by applicant): Eye diseases leading to visual impairment and blindness are an important source of morbidity, decrease the quality of life for people of all ages, and place a substantial burden on health care resources. Eye care professionals, who diagnose vision disorders and practice sight-saving treatments, rely on findings from comparative effectiveness research to make well-informed health care decisions. Despite the critical need for better information, there are few established infrastructures for performing eyes and vision systematic reviews in the US only one, the Cochrane Collaboration's Eyes and Vision Group. US Satellite (CEVG(gUS) is subject specific, sustainable, provides education and facilitates collaboration by allowing anyone to contribute, as long as the research is high quality. CEVG@US. which has been producing reviews since 1997. ensures important eyes and vision systematic review topics are prioritized, performed, disseminated, and kept up-to-date; it educates and builds a workforce that performs high quality systematic reviews; and provides a forum for US researchers to play an instrumental role in developing methods for comparative effectiveness research. Building on CEVG's previous experiences and achievements, the over-arching objective of this proposal is to serve as a coordinating center for comparative effectiveness research, and specifically Cochrane systematic reviews, in eyes and vision in the US. This role is comparable to that of a coordinating center for a clinical trial or clinical research network. Specifically, the aims are to 1) educate and build a sustainable vision science workforce in comparative effectiveness research; 2) identify targeted areas where evidence is needed; 3) prepare and keep up-to-date systematic reviews addressing targeted questions; 4) conduct research on methods to identify evidence gaps; 5) build a study-based, publicly available vision trials register; 6) conduct methodological research in systematic reviews; 7) disseminate the results of our research. The proposed research is served by the long standing infrastructure of the Cochrane Collaboration, and is led by a highly trained research team. RELEVANCE: By conducting and supporting comparative effectiveness research, training eyes and vision practitioners and researchers, disseminating health information, the outcome of the proposed work will have substantial impact on preventing or treating eye diseases and/or visual impairment, and improving the quality of life for people of all ages.

描述（由申请人提供）：导致视觉障碍和失明的眼部疾病是发病率的重要来源，降低了各个年龄段的人们的生活质量，并给医疗保健资源带来了重大负担。诊断视力障碍和练习视力治疗的眼保健专业人员依靠比较有效性研究的发现来做出明确的医疗保健决策。 尽管需要更好的信息，但很少有建立的基础架构可以在美国进行眼睛和视力系统评价，这是Cochrane Collaboration的眼睛和愿景小组。美国卫星（CEVG（GUS）是特定的，可持续的，可持续的，可以通过允许任何人做出贡献来提供教育并促进协作，只要研究是高质量的。CEVG@us。自1997年以来一直在进行评论。确保重要的眼睛和愿景的系统评论可在良好的过程中进行，并保持良好的效果，并提供良好的效果；该论坛优先;研究人员在开发比较有效性研究的方法中发挥了作用，该提案的过度目标是作为比较有效性研究的协调中心。并在比较有效性研究中建立可持续的视觉科学劳动力； 2）确定需要证据的目标区域； 3）准备并保持最新的系统评价，以解决针对性问题； 4）对鉴定证据差距的方法进行研究； 5）建立一个基于学习的公开视觉试验登记册； 6）在系统评价中进行方法论研究； 7）传播我们的研究结果。拟议的研究由Cochrane合作的长期建立基础设施提供服务，并由训练有素的研究团队领导。 相关性：通过进行和支持比较有效性研究，训练眼睛和视力从业者和研究人员，传播健康信息，拟议工作的结果将对预防或治疗眼病和/或视觉障碍以及改善所有年龄段人的生活质量产生重大影响。